4Filed Aug 16, 8:00 PM ET

Foresight Autonomous (FRSX) VP Sivan Scherf-Siboni Receives Award

$FRSX · Foresight Autonomous Holdings Ltd.

Research Summary

AI-generated summary of this SEC filing

Updated

Foresight Autonomous (FRSX) VP Sivan Scherf-Siboni Receives Award

What Happened

  • Sivan Scherf-Siboni, Vice President of Human Resources at Foresight Autonomous Holdings Ltd. (FRSX), received an award of 4,000,000 restricted share units (RSUs) on 2026-08-13. The Form 4 reports an acquisition price of $0.00 per share (total reported value $0) because these are time-based RSUs that vest in the future rather than an immediate cash purchase.
  • Each RSU represents the right to receive one ordinary share (no par value) upon vesting. The shares are ordinary shares underlying the company’s American Depository Shares (ADS), where one ADS represents 90 ordinary shares — 4,000,000 ordinary shares equate to approximately 44,444 ADS.

Key Details

  • Transaction date: 2026-08-13; Form 4 filed 2026-08-17 (timely filed within reporting window).
  • Transaction type: Award/Grant (Code A) of 4,000,000 RSUs at $0.00 per share (reported value $0).
  • Vesting schedule: RSUs issuable through January 1, 2029 (each RSU = 1 ordinary share).
  • ADS conversion: 1 ADS = 90 ordinary shares; 4,000,000 ordinary shares ≈ 44,444 ADS.
  • Shares owned after transaction: Not specified in the Form 4.
  • Notable footnote: The reported securities are owned by Moshe Scherf (the spouse). Mrs. Scherf-Siboni may be deemed to beneficially own them to the extent of her spouse’s pecuniary interest; she disclaims beneficial ownership except to that extent.

Context

  • RSUs are a compensation/retention award that vest over time; they are not an open-market purchase or sale and do not necessarily indicate immediate buying/selling sentiment. If and when RSUs vest and are converted into ordinary shares or ADSs, taxable events and potential sales could follow depending on the holder’s decisions and company policies.
  • This filing reports an award rather than an exercise, sale, or purchase — useful for monitoring potential future dilution and insider compensation but not a direct cash outlay or realized transaction.